These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 30825650

  • 1. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 2. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 3. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.
    Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R.
    Bone; 2020 May; 134():115300. PubMed ID: 32112990
    [Abstract] [Full Text] [Related]

  • 4. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 5. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 16; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 6. Hypophosphatasia: An overview For 2017.
    Whyte MP.
    Bone; 2017 Sep 16; 102():15-25. PubMed ID: 28238808
    [Abstract] [Full Text] [Related]

  • 7. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct 16; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 8. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 10; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B6 metabolism.
    Whyte MP, Zhang F, Mack KE, Wenkert D, Gottesman GS, Ericson KL, Cole JT, Coburn SP.
    Bone; 2024 Apr 10; 181():117033. PubMed ID: 38307176
    [Abstract] [Full Text] [Related]

  • 15. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.
    Whyte MP, Fujita KP, Moseley S, Thompson DD, McAlister WH.
    J Bone Miner Res; 2018 May 10; 33(5):868-874. PubMed ID: 29297597
    [Abstract] [Full Text] [Related]

  • 16. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F, Ali DS, Almonaei K, Al-Alwani H, Khan AA, Brandi ML.
    Osteoporos Int; 2024 Apr 10; 35(4):717-725. PubMed ID: 37993691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
    Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millán JL, Hatch NE.
    Bone; 2015 Sep 10; 78():203-11. PubMed ID: 25959417
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.